LIF and nasopharyngeal carcinoma: Nasopharyngeal carcinoma cells in vitro and xenograft mouse studies were treated with soluble LIF receptors, LIF antagonists (decreases LIF-mediated effects), or mTOR inhibitors, leading to growth arrest and increased sensitivity to gamma radiation [117].